» Articles » PMID: 24027076

Estimating and Comparing Time-dependent Areas Under Receiver Operating Characteristic Curves for Censored Event Times with Competing Risks

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2013 Sep 13
PMID 24027076
Citations 770
Authors
Affiliations
Soon will be listed here.
Abstract

The area under the time-dependent ROC curve (AUC) may be used to quantify the ability of a marker to predict the onset of a clinical outcome in the future. For survival analysis with competing risks, two alternative definitions of the specificity may be proposed depending of the way to deal with subjects who undergo the competing events. In this work, we propose nonparametric inverse probability of censoring weighting estimators of the AUC corresponding to these two definitions, and we study their asymptotic properties. We derive confidence intervals and test statistics for the equality of the AUCs obtained with two markers measured on the same subjects. A simulation study is performed to investigate the finite sample behaviour of the test and the confidence intervals. The method is applied to the French cohort PAQUID to compare the abilities of two psychometric tests to predict dementia onset in the elderly accounting for death without dementia competing risk. The 'timeROC' R package is provided to make the methodology easily usable.

Citing Articles

Multi-omics analysis revealed the novel role of NQO1 in microenvironment, prognosis and immunotherapy of hepatocellular carcinoma.

Tang Y, Hu H, Chen S, Hao B, Xu X, Zhu H Sci Rep. 2025; 15(1):8591.

PMID: 40074806 PMC: 11903666. DOI: 10.1038/s41598-025-92700-7.


Evaluating PREDICT and developing outcome prediction models in early-onset breast cancer using data from Alberta, Canada.

Basmadjian R, Xu Y, Quan M, Lupichuk S, Cheung W, Brenner D Breast Cancer Res Treat. 2025; .

PMID: 40072699 DOI: 10.1007/s10549-025-07654-1.


Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool.

Swinnerton K, Fillmore N, Vo A, La J, Elbers D, Brophy M EClinicalMedicine. 2025; 81:103114.

PMID: 40070694 PMC: 11893359. DOI: 10.1016/j.eclinm.2025.103114.


Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.

Gairing S, Mildenberger P, Gile J, Artusa F, Scheiner B, Leyh C JHEP Rep. 2025; 7(3):101295.

PMID: 40059970 PMC: 11889551. DOI: 10.1016/j.jhepr.2024.101295.


Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification.

DAoust T, Clocchiatti-Tuozzo S, Rivier C, Mishra A, Hachiya T, Grenier-Boley B Alzheimers Dement. 2025; 21(3):e70014.

PMID: 40042447 PMC: 11881617. DOI: 10.1002/alz.70014.